| Financial Year |
March 31 2023 |
| Monetary Funds |
169,331,198.33 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
665,000.00 |
| Accounts Receivable |
60,964,429.07 |
| Advances to Suppliers |
17,777,664.34 |
| Other Receivables |
717,959.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
139,323,601.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,160,267.22 |
| Total Current Assets |
419,307,132.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,812,850.55 |
| Fixed Assetes |
181,742,316.59 |
| Under-construction Projects |
1,798,506.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,709,346.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,581,986.54 |
| Other Non-Current Assets |
1,987,037.76 |
| Sub-Total of Non-Current Assets |
260,632,044.59 |
| Total Assets |
679,939,177.40 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,000,000.00 |
| Accounts Payable |
35,493,134.25 |
| Accounts Received In Advance |
2,584,000.00 |
| Employee Compensation Payable |
6,449,061.55 |
| Taxes Payable |
857,783.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,546,795.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
336,162.01 |
| Sub-Total of Current Liabilities |
56,267,286.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
71,265.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,163,590.54 |
| Total Liabilities |
61,430,876.80 |
| Paid-In Capital(Or Share Stock) |
88,800,000.00 |
| Capital Surplus |
238,063,314.26 |
| Surplus Reserve |
43,117,769.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
248,527,217.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
618,508,300.60 |
| Owner's Equity（Stockholder's Equity） |
618,508,300.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
679,939,177.40 |
